5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Europe Veterinary Healthcare Market is Segmented on the basis of Product (by Therapeutics and by Diagnostics), Animal Type, and Geography
Europe veterinary healthcare is primarily driven by increasing initiatives by various governments, improved animal healthcare, and rising animal adoption in European countries. According to the People's Dispensary for Sick Animals, in 2018, 49% of the adults in the United Kingdom owned a pet. Among them, 25% of the adults owned a pet cat (with an estimated population of 11.1 million pet cats) and 24% of the adults owned a pet dog (with an estimated population of 8.9 million pet dogs).
Furthermore, advancements in animal diagnostic technologies for accurate diagnostics and the presence of some of the key market players in the region expected to propel the market growth. For instance, in April 2019, Vita Animal Health has launched a range of veterinary specific animal health supplements in the United Kingdom. The range is already established in several European countries and includes products to support cardiovascular, joint and skin health in cats, dogs, rabbits and horses.
However, the increasing costs of animal testing and veterinary services, shortage of farmworkers and veterinarians, and the use of counterfeit medicines are restraining the growth of the European veterinary healthcare market.
As per the scope of this report, the veterinary healthcare market comprises therapeutic and diagnostic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canines, felines, and equines. Farm animals include bovine, poultry, and porcine.
|By Animal Type|
|Dogs and Cats|
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
The major players in the European veterinary healthcare market are engaging in various growth strategies, such as collaborations, partnerships, agreements, mergers, and acquisitions, in order to enhance their market presence.
In June 2018, Regeneron entered into a collaboration agreement with Zoetis, to research antibody therapies to be used in animal health. In 2018, Boehringer Ingelheim announced its plans to invest EUR 65 million in France, for the production of avian vaccines, as its demand increased due to an increase in poultry consumption.
The key market players operating in European veterinary healthcare market include Zoetis Animal Healthcare, Boehringer Ingelheim, Ceva , Elanco and Vetoquinol among others.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.1.1 Advanced Technology Leading to Innovations in Animal Healthcare
4.1.2 Increasing Pet Ownership
4.1.3 Increasing Initiatives by Governments and Animal Welfare Associations
4.2 Market Restraints
4.2.1 Lack of Veterinarians and Shortage of Skilled Farm Workers
4.2.2 Decline in the Number of Farm Animals in Europe
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 By Therapeutics
18.104.22.168 Medical Feed Additives
22.214.171.124 Other Therapeutics
5.1.2 By Diagnostics
126.96.36.199 Immunodiagnostic Tests
188.8.131.52 Molecular Diagnostics
184.108.40.206 Diagnostic Imaging
220.127.116.11 Clinical Chemistry
18.104.22.168 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.6 Other Animals
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Zoetis Animal Healthcare
6.1.2 Abaxis Inc.
6.1.4 Bayer AG
6.1.5 Ceva Animal Health Inc.
6.1.7 Boehringer Ingelheim International GmbH
6.1.8 Idexx Laboratories
6.1.9 ECO Animal Health
6.1.10 MSD Animal Health
6.1.11 Vetoquinol UK Limited
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments